Genetic Predisposition to the Thrombomicroangiopathies (GP-TMAs)

$241,405U54FY2013HLNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 39690307 Paper 38645143 Paper 37156755 Paper 35661836 Paper 33548557 Paper 33539617 Paper 33445952 Paper 32948386 Paper 32145144 Paper 31901157 Paper 31354089 Paper 31331919 Paper 31312772 Paper 30700419 Paper 30670593 Paper 30586751 Paper 30451376 Paper 30234153 Paper 30194803 Paper 30071045 Paper 29531168 Paper 29511224 Paper 29440720 Paper 29211671 Paper 28768626 Paper 28652462 Paper 28494585 Paper 28294177 Paper 28165899 Paper 27959629 Paper 27918545 Paper 27646948 Paper 27642757 Paper 27624125 Paper 27572114 Paper 27462078 Paper 27443162 Paper 27435675 Paper 27359051 Paper 27347732 Paper 27344059 Paper 27236750 Paper 27208462 Paper 27110430 Paper 27110093 Paper 27052467 Paper 27013439 Paper 26966178 Paper 26947396 Paper 26913032 Paper 26779465 Paper 26769047 Paper 26763231 Paper 26637781 Paper 26501415 Paper 26482989 Paper 26471127 Paper 26391536 Paper 26260209 Paper 26216877 Paper 26186912 Paper 26083278 Paper 26080701 Paper 26054645 Paper 26045594 Paper 25857553 Paper 25832548 Paper 25819276 Paper 25788521 Paper 25664608 Paper 25660839 Paper 25660530 Paper 25652900 Paper 25651565 Paper 25613924 Paper 25608561 Paper 25544610 Paper 25512528 Paper 25495259 Paper 25425244 Paper 25369995 Paper 25327788 Paper 25246013 Paper 25200815 Paper 25168949 Paper 25157820 Paper 25149641 Paper 25034031 Paper 24847005 Paper 24844358 Paper 24832959 Paper 24821807 Paper 24300584 Paper 24178300 Paper 24113284 Paper 24063304 Paper 23947609 Paper 23929727 Paper 23775088 Paper 23773695

Abstract

Specific Aims The goals of this project are to identify genetic variants that predispose to thrombotic microangiopathies and validate them via functional studies. The initial focus will be on mutations in the complement and clotting systems in patients with atypical hemolytic uremic syndrome (aHUS), thrombotic thrombocytopenic purpura (TTP) and, especially, the pregnancy related disorder preeclampsia (PE). The strategic approach will center on next generation sequencing, specifically targeted deep resequencing and exomic sequencing of TMA patient cohorts. To tackle this project, we will take advantage of the considerable expertise in genomics at Washington University as well as senior investigators with much know-how in defining the functional implications of mutants in these two great serine protease pathways of human plasma that protect us from bleeding and infections.

View original record on NIH RePORTER →